Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Clinical actionability of molecular targets in endometrial cancer.
Nat Rev Cancer. 2019 Sep;19(9):510-521. doi: 10.1038/s41568-019-0177-x. Epub 2019 Aug 6.
Nat Rev Cancer. 2019.
PMID: 31388127
Free PMC article.
Review.
KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.
Rudd ML, Hansen NF, Zhang X, Urick ME, Zhang S, Merino MJ; National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program; Mullikin JC, Brody LC, Bell DW.
Rudd ML, et al.
PLoS One. 2022 Jan 26;17(1):e0251286. doi: 10.1371/journal.pone.0251286. eCollection 2022.
PLoS One. 2022.
PMID: 35081118
Free PMC article.
Item in Clipboard
High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.
Urick ME, Yu EJ, Bell DW.
Urick ME, et al.
Cancer. 2021 Aug 15;127(16):2905-2915. doi: 10.1002/cncr.33567. Epub 2021 Apr 19.
Cancer. 2021.
PMID: 33872388
Free PMC article.
Item in Clipboard
Cite
Cite